Arcus Biosciences, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.41M8.35M15.00M78.00M383.00M112.00M117.00M258.00M
Gross Profit 1.41M8.35M15.00M78.00M383.00M112.00M117.00M258.00M
Operating items
Research & Development 47.22M49.65M78.48M159.00M257.00M288.00M340.00M448.00M
Selling, General & Administrative 7.64M13.57M25.23M43.00M72.00M104.00M117.00M120.00M
Other Operating Expenses 20.00M
Operating Expenses 54.85M63.21M103.71M202.00M329.00M392.00M457.00M588.00M
Operating Income -53.44M-54.86M-88.71M-124.00M54.00M-280.00M-340.00M-330.00M
EBIT -53.44M-54.86M-88.71M-124.00M54.00M-280.00M-340.00M-330.00M
Non-operating items
Interest & Investment Income 0.78M4.92M5.20M1.00M1.00M16.00M41.00M52.00M
Non Operating Income 0.36M5.26M4.00M1.00M1.00M14.00M39.00M48.00M
Net income details
EBT -52.67M-49.94M-85.14M-123.00M55.00M-266.00M-301.00M-282.00M
Tax Provisions 2.00M1.00M6.00M1.00M
Profit After Tax -53.08M-49.59M-84.71M-123.00M53.00M-267.00M-307.00M-283.00M
Equity Income -0.42M-0.89M-1.20M0.61M
Income from Continuing Operations -52.67M-49.94M-85.14M-123.00M53.00M-267.00M-307.00M-283.00M
Consolidated Net Income -52.67M-49.94M-85.14M-123.00M53.00M-267.00M-307.00M-283.00M
Income towards Parent Company -52.67M-49.94M-85.14M-123.00M53.00M-267.00M-307.00M-283.00M
Net Income towards Common Stockholders -52.67M-49.94M-85.14M-123.00M53.00M-267.00M-307.00M-283.00M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 41.65M44.45M45.86M64.92M70.25M72.41M74.86M91.51M
Shares Outstanding (Diluted Average) 74.00M72.00M74.00M90.10M
EBITDA -53.10M-49.66M-84.54M-122.88M51.52M-280.00M-340.00M-330.00M
Tax Rate 3.64%